Abstract:Background Septic cardiomyopathy (SC) is characterized by myocardial dysfunction caused by sepsis and constitutes one of the serious complications of sepsis. Pyroptosis is a unique proinflammatory programmed cell death process. However, the role of pyroptosis in the development of SC remains unclear, and further study is required. The purpose of this study is to identify pyroptosis-related genes (PRGs) in SC and explore the mechanism of pyroptosis involved in the regulation of SC formation and progression. Methods Differential expression analysis and enrichment analysis were performed on the SC-related dataset GSE79962 to identify differentially expressed genes (DEGs). PRGs were screened by intersecting genes associated with pyroptosis in previous studies with the DEGs obtained from GSE79962 . The expression pattern of them was studied based on their raw expression data. Additionally, corresponding online databases were used to predict miRNAs, transcription factors (TFs) and therapeutic agents of PRGs. Lipopolysaccharide (LPS)-induced cell damage models in H9C2 and AC16 cell lines were constructed, cell activity was detected by CCK-8 and cell pyroptosis were detected by Hoechst33342/PI staining. Furthermore, these PRGs were verified in the external datasets ( GSE53007 and GSE142615 ) and LPS-induced cell damage model. Finally, the effect of siRNA-mediated PRGs knockdown on the pyroptosis phenotype was examined. Results A total of 1,206 DEGs were screened, consisting of 663 high-expressed genes and 543 low-expressed genes. Among them, ten PRGs (SOD2, GJA1, TIMP3, TAP1, TIMP1, NOD1, TP53, CPTP, CASP1 and SAT1) were identified, and they were mainly enriched in “Pyroptosis”, “Ferroptosis”, “Longevity regulating pathway”, and “NOD-like receptor signaling pathway”. A total of 147 miRNAs, 31 TFs and 13 therapeutic drugs were predicted targeting the PRGs. The expression trends of SOD2 were confirmed in both the external datasets and LPS-induced cell damage models. Knockdown of SOD2 induced increased pyroptosis in the AC16 LPS-induced cell damage model. Conclusions In this study, we demonstrated that SOD2 is highly expressed in both the SC and LPS-induced cell damage models. Knockdown of SOD2 led to a significant increase in pyroptosis in the AC16 LPS-induced cell damage model. These findings suggest that SOD2 may serve as a potential target for the diagnosis and treatment of SC.

Pyroptosis Patterns Are Involved in Immune Microenvironment Regulation of Dilated Cardiomyopathy

Research Progresses of Molecular Mechanism of Pyroptosis and Its Related Diseases

Research Progress of the Relationship Between Pyroptosis and Disease

Role of pyroptosis in diabetic cardiomyopathy: an updated review

Pyroptosis: mechanisms and links with diabetic cardiomyopathy

Pyroptosis and Its Regulation in Diabetic Cardiomyopathy

Role of pyroptosis in the pathogenesis and treatment of diseases

New Insights into the Mechanisms of Pyroptosis and Implications for Diabetic Kidney Disease

Pyroptosis in cardiovascular diseases: Pumping gasdermin on the fire

Pyroptosis: A New Regulating Mechanism in Cardiovascular Disease

Pyroptosis: A pro-inflammatory type of cell death in cardiovascular disease

GSDMD-mediated Pyroptosis Promotes Cardiac Remodeling in Pressure Overload

Pyroptosis: Role and Mechanisms in Cardiovascular Disease

The Role of Pyroptosis in Coronary Heart Disease

Pyroptosis, metabolism, and tumor immune microenvironment

Progress in research on pyroptosis and cardiovascular diseases

Transcriptome analysis reveals the mechanism of pyroptosis-related genes in septic cardiomyopathy

Role Of Pyroptosis In Cardiovascular Diseases And Its Therapeutic Implications

NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy

GSDMD-Mediated Cardiomyocyte Pyroptosis Promotes Myocardial I/R Injury

LncRNA KCNQ1OT1 Mediates Pyroptosis in Diabetic Cardiomyopathy.